LSE · RUA.L
RUA Life Sciences plc
£0.28+£0.01 (+2.96%)
RUA Life Sciences plc’s quoted price sits in the upper half of its reported 52-week range, 10.32% below the high.
Loading market information…
LSE · FUM.L · GBp
Stock price, earnings
Quote as of Oct 30, 2026, 09:48 AM UTC. Cached market data; not a live quote.
One-year closing-price history · GBp. Historical prices are not a forecast.
Futura Medical plc’s quoted price sits in the lower half of its reported 52-week range, 93.29% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Futura Medical plc’s next earnings report is currently expected on Apr 14, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Futura Medical plc’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Futura Medical plc operates as a pharmaceutical firm specializing in the creation and advancement of consumer healthcare products. The company primarily targets the sexual health and pain management sectors. Its leading innovation is MED3000, a topical gel specifically formulated to treat erectile dysfunction. Additionally, Futura Medical offers a variety of pain relief solutions, including TPR100, a topical diclofenac gel; CBD100, a cannabidiol-based topical application; and TIB200, an ibuprofen topical gel. Established in 2001, the company is headquartered in Guildford, United Kingdom.
Latest available per-share figures in GBP. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:08 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Apr 5, 2023 |
| -£0.01 |
| £0.00 |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
£0.28+£0.01 (+2.96%)
RUA Life Sciences plc’s quoted price sits in the upper half of its reported 52-week range, 10.32% below the high.
£0.02+£0.00 (+0.71%)
Genflow Biosciences Plc’s quoted price sits in the lower half of its reported 52-week range, 40.93% below the high.
£0.01-£0.00 (-3.2%)
CelLBxHealth plc’s quoted price sits in the lower half of its reported 52-week range, 78.39% below the high.
£0.06-£0.00 (-1.72%)
OptiBiotix Health Plc’s quoted price sits in the lower half of its reported 52-week range, 36.67% below the high.
